The effects of Bruton tyrosine kinase inhibition on chemotaxis and superoxide generation in human neutrophils

J Clin Immunol. 2014 Jul;34(5):555-60. doi: 10.1007/s10875-014-0046-z. Epub 2014 Apr 26.

Abstract

Purpose: The role of the Bruton tyrosine kinase (Btk) protein in neutrophil function has been evaluated using neutrophils from healthy volunteers after incubation with a Btk inhibitor, leflunomide metabolite analog (LFM-A13), suggesting an important role for Btk in neutrophil function. We sought to determine the role of Btk protein on neutrophil superoxide generation and chemotaxis stimulated by N-formyl-methionine-leucine-phenylalanine (fMLP).

Methods: Chemotaxis was assayed on agarose gel and superoxide generation by cytochrome C reduction. The affects of LFM-A13 on chemotaxis and superoxide generation in unstimulated and fMLP stimulated neutrophils were studied in Btk deficient neutrophils from XLA patients compared with matched controls analyzed simultaneously.

Results: Chemotaxis and stimulated superoxide production were similar in the normal and Btk deficient neutrophils and were similarly inhibited by LFM-A13. In one patient, LFMA13 had no effect on superoxide generation in Btk deficient neutrophils up to a concentration of 25 microM, while inhibited superoxide production by control neutrophils.

Conclusions: Our results suggest that Btk does not have a specific role in neutrophil fMLP-stimulated superoxide generation and chemotaxis since these activities were similarly inhibited by LFM-A13 in Btk deficient and normal neutrophils. The lack of superoxide generation following Btk inhibition by LFM-A13 in Btk deficient neutrophils from one patient may suggest some heterogeneity in the role of Btk in fMLP induced neutrophil superoxide generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Agammaglobulinaemia Tyrosine Kinase
  • Agammaglobulinemia / enzymology*
  • Agammaglobulinemia / genetics
  • Agammaglobulinemia / pathology
  • Amides / pharmacology*
  • Case-Control Studies
  • Chemotactic Factors / pharmacology
  • Chemotaxis, Leukocyte / drug effects
  • Child
  • Child, Preschool
  • Gene Expression
  • Genetic Diseases, X-Linked / enzymology*
  • Genetic Diseases, X-Linked / genetics
  • Genetic Diseases, X-Linked / pathology
  • Humans
  • Infant
  • Male
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects*
  • Neutrophils / enzymology
  • Neutrophils / pathology
  • Nitriles / pharmacology*
  • Primary Cell Culture
  • Protein Kinase Inhibitors / pharmacology*
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Protein-Tyrosine Kinases / genetics
  • Protein-Tyrosine Kinases / metabolism
  • Superoxides / metabolism*
  • Young Adult

Substances

  • Amides
  • Chemotactic Factors
  • LFM A13
  • Nitriles
  • Protein Kinase Inhibitors
  • Superoxides
  • N-Formylmethionine Leucyl-Phenylalanine
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human

Supplementary concepts

  • Bruton type agammaglobulinemia